OS Therapies Inc - Common Stock, par value $0.001 per share (OSTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
OSTX on NYSE
Shares outstanding
31,500,824
Price per share
$1.40
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1,563,221
Total reported value
$3,065,164
% of total 13F portfolios
0%
Share change
+959,494
Value change
+$1,884,295
Number of holders
25
Price from insider filings
$1.40
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of OS Therapies Inc - Common Stock, par value $0.001 per share (OSTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SATTERFIELD THOMAS A JR 9.4% +58% $5,296,658 +$3,141,967 3,115,681 +146% Thomas A. Satterfield, Jr. 30 Jun 2025
Auerbach Shalom 8.5% -14% $4,899,953 -$18,300 2,677,570 -0.37% Shalom Auerbach 29 Jul 2025
Ayala Pharmaceuticals, Inc. 10% $4,328,430 2,164,215 AYALA PHARMACEUTICALS, INC. 09 Apr 2025

As of 30 Sep 2025, 25 institutional investors reported holding 1,563,221 shares of OS Therapies Inc - Common Stock, par value $0.001 per share (OSTX). This represents 5% of the company’s total 31,500,824 outstanding shares.

Institutional Holders of OS Therapies Inc - Common Stock, par value $0.001 per share (OSTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 13,917 $19,484 -$4,176 $1.40 2
2025 Q3 1,563,221 $3,065,164 +$1,884,295 $1.96 25
2025 Q2 603,727 $1,134,576 +$402,668 $1.88 13
2025 Q1 389,286 $599,294 +$293,725 $1.54 6
2024 Q4 145,004 $620,617 +$9,243 $4.28 5
2024 Q3 160,043 $447,782 +$447,782 $2.80 7